Patents by Inventor Bjorn Metzler

Bjorn Metzler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220162227
    Abstract: The present invention relates to novel methods for the preparation of 1,3-benzodioxole heterocyclic compounds. The compounds are useful as PDE4 inhibitors.
    Type: Application
    Filed: December 1, 2021
    Publication date: May 26, 2022
    Inventors: Allan Carsten Dahl, Johan Eriksson Bajtner, Esben Paul Krogh Olsen, Bjørn Metzler
  • Patent number: 11220514
    Abstract: The present invention relates to novel methods for the preparation of 1,3-benzodioxole heterocyclic compounds of formula (I). The compounds are useful as PDE4 inhibitors.
    Type: Grant
    Filed: June 19, 2018
    Date of Patent: January 11, 2022
    Assignee: UNION therapeutics A/S
    Inventors: Allan Carsten Dahl, Johan Eriksson Bajtner, Esben Paul Krogh Olsen, Bjørn Metzler
  • Publication number: 20210147440
    Abstract: The present invention relates to novel methods for the preparation of 1,3-benzodioxole heterocyclic compounds of formula (I). The compounds are useful as PDE4 inhibitors.
    Type: Application
    Filed: June 19, 2018
    Publication date: May 20, 2021
    Inventors: Allan Carsten DAHL, Johan Eriksson BAJTNER, Esben Paul Krogh OLSEN, Bjørn METZLER
  • Patent number: 9908894
    Abstract: The present invention relates to novel methods for the preparation of 1,3-benzodioxole heterocyclic compounds and intermediates for the same. The compounds are useful as PDE4 inhibitors.
    Type: Grant
    Filed: June 22, 2015
    Date of Patent: March 6, 2018
    Assignee: LEO Pharma A/S
    Inventors: Bjorn Metzler, Andre Faldt
  • Publication number: 20170137438
    Abstract: The present invention relates to novel methods for the preparation of 1,3-benzodioxole heterocyclic compounds and intermediates for the same. The compounds are useful as PDE4 inhibitors.
    Type: Application
    Filed: June 22, 2015
    Publication date: May 18, 2017
    Inventors: Bjorn Metzler, Andre Faldt